Madame Bioscience Public Company Limited Receivables

Madame Bioscience Public Company Limited (GLOCON.BK) currently reports a receivables of $170M as of June 2026. That compares with $220M in the prior-year period — down 22.5% year over year. Use the charts on this page to explore Madame Bioscience Public Company Limited's receivables history and peer comparisons.

Madame Bioscience Public Company Limited's receivables decreased from $220M to $170M — a 22.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Madame Bioscience Public Company Limited reported $170M in receivables as of June 2026. That compares with $220M in the prior-year period — down 22.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Madame Bioscience Public Company Limited, and consider following GLOCON.BK for alerts when major investors trade the stock.